The Quest Diagnostics Drug Testing Index™ (DTI) is arguably the industry’s longest standing, most frequently relied upon resource for drug use patterns within the American workforce. Our presenter, Dr. Barry Sample, Director of Science and Technology, Quest Diagnostics, is responsible gathering, publishing and interpreting the trends found within the data.
Join us on Tuesday, October 7 at 1 p.m. CT for a webinar, “Tracking the Trends: Insights from the Drug Testing Index,” that will highlight key findings and the latest drug test positivity data by workforce type, testing reason, drug category and specimen type. Register now.
The mission of the Substance Abuse Program Administrators Association (SAPAA) is to establish, promote and communicate the highest standards of quality, integrity and professionalism in the administration of workplace substance abuse prevention programs through education, training and the exchange of ideas.
As a platinum sponsor of this year’s SAPAA conference, we couldn’t be more excited about this gathering of thought leaders and experts from across the drug testing industry. We believe in SAPAA’s mission and we’re honored to have our name associated with this organization. Quest Diagnostics prides itself on being there for our clients and for our industry. Through this sponsorship, we’re able to show that We’re There When You Need Us™ is more than just a slogan, it’s a commitment to supporting the values that drive us.
It’s with that spirit of collaboration and partnership in mind that we’d like to invite you to connect with us at the event on September 24-27 in Richmond, VA. If you plan to attend the conference, stop by booths #4 and #7 to learn more about our lab-based and instant drug testing products and services. And join us on Friday, September 26 at 10:45 A.M. to hear industry experts, Dr. Barry Sample, Director of Science and Technology at Quest Diagnostics, and D. Faye Caldwell discuss “When is Marijuana a street drug and when is it a medicine?”